Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease
Open Access
- 24 July 2002
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 82 (3), 615-624
- https://doi.org/10.1046/j.1471-4159.2002.00990.x
Abstract
We examined the effect of pioglitazone, a peroxisome proliferator-activated receptor-γ (PPARγ)agonistofthethiazolidinedione class, on dopaminergic nerve cell death and glial activation in the 1-methy...This publication has 38 references indexed in Scilit:
- Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: A real-time PCR studyMolecular and Cellular Endocrinology, 2006
- Role of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) and its natural ligand 15‐deoxy‐Δ12,14‐prostaglandin J2in the regulation of microglial functionsEuropean Journal of Neuroscience, 2000
- The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in MouseExperimental Neurology, 1999
- Distribution of mRNAs Encoding the Peroxisome Proliferator‐Activated Receptor α, β, and γ and the Retinoid X Receptor α, β, and γ in Rat Central Nervous SystemJournal of Neurochemistry, 1998
- Microglia Responses in the CNS Following Sciatic Nerve Transection in C57BL/Wldsand BALB/c MiceExperimental Neurology, 1997
- Microglia: a sensor for pathological events in the CNSTrends in Neurosciences, 1996
- Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patientsNeuroscience Letters, 1994
- Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.The Journal of Experimental Medicine, 1993
- Sites and Mechanisms of Function-Related Changes in Energy Metabolism in the Nervous SystemDevelopmental Neuroscience, 1993
- Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's diseaseNature, 1988